St. Louis – Orion Genomics today announced that it has entered into a multi-year collaboration and license agreement with the molecular diagnostics unit of Novartis Pharma AG. Under the collaboration, the parties seek to discover novel epigenetic biomarkers, and both parties have rights to independently develop and commercialize diagnostic products in their respective fields. Under […]
Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute – Plans development of extremely high-sensitivity blood-based diagnostic applications of DNA mutation detection for cancer and other diseases OMAHA, Neb. — Transgenomic, Inc. (OTC Bulletin Board: TBIO). The company announced today that it has licensed a high-sensitivity mutation detection technology called Cold-PCR from […]
AUSTIN, Texas–Asuragen, Inc. announced today that it has received over $3.8 million in new grant funding for 2009 from the Small Business Innovative Research (SBIR), Small Business Technology Transfer (STTR), and American Recovery and Reinvestment Act (ARRA) funded initiatives of the National Institutes of Health (NIH) to further its development of molecular diagnostics for oncology […]
NTD Laboratories’ free-Beta hCG screening test for Down Syndrome now covered by Aetna WALTHAM, Mass –PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that its NTD Laboratories business will be a participant in Aetna’s network of contracted laboratories. PerkinElmer NTD Laboratories is the exclusive […]
SALT LAKE CITY–Idaho Technology’s Joint Biological Agent Identification and Diagnostic System (JBAIDS) has been approved by the military to run tests for the H1N1 virus. Deployed across the globe, including in Iraq and Afghanistan, by all four branches of the military, the JBAIDS instrument will be used to test military personnel and their families for […]
WALTHAM, Mass.–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its previously announced acquisition of B.R.A.H.M.S. AG for €330 million (approximately $470 million USD). B.R.A.H.M.S. generated 2008 revenues of €75 million (approximately $105 million USD), and is expected to be accretive to adjusted earnings per share […]
NOVATO, CA – Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that on September 16th, 2009, the company licensed from Roche Molecular Systems (Roche), a family of patents covering practice of the 5’ Nuclease process. Biosearch becomes the first commercial oligonucleotide manufacturer to […]
Momentum continues as company moves to larger offices and hires more senior staff Ottawa, ON – Dr. Paul Lem, Founder, and the Board of Directors of Spartan Bioscience Inc., a Canadian molecular diagnostics company that develops, manufactures, and markets DNA analyzers for on-demand applications, today announced the appointment of Mr. Larry D’Andrea as CEO. This […]
MUKILTEO, Wash. — CombiMatrix Corporation (Nasdaq:CBMX – News) today announced that the U.S. 9th Circuit Court of Appeals (the “Court”) has set a date for an oral hearing in its litigation with National Union Fire Insurance Company of Pittsburgh, PA, an AIG company (NYSE:AIG – News). This oral hearing is a short session (each side […]
SAIC-Frederick and Roche Enter into a Research Collaboration on Technology Advancements for Cancer Gene Sequencing MADISON, Wis. — National Cancer Institute contractor SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International Corporation (NYSE: SAI), and Roche Applied Science, a division of Roche Diagnostics Corporation (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY), have signed a collaboration agreement […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
